Apeloa Pharmaceutical Hits Day High with Strong 3.45% Intraday Surge

Apeloa Pharmaceutical Co., Ltd. has shown notable activity today, gaining 3.45% on March 6, 2026. The stock reached an intraday high of CNY 17.80, reflecting a significant moment in its trading session. Despite this daily uptick, the company's performance over the past week has been less favorable, with a decline of 2.1%. In the broader context, Apeloa's one-year performance stands at 3.45%, which is considerably lower than the China Shanghai Composite's impressive return of 21.98%. The company has faced challenges, including a reported drop in net sales of 14.55% and negative results in the last two consecutive quarters. Financial metrics indicate that Apeloa operates with a market capitalization of CNY 21,412 million and a price-to-earnings ratio of 20.00. The company's return on equity is recorded at 13.29%, while its operating cash flow has reached a low of CNY 847.13 million. As Apeloa navigates its current market position, the stock's recent activity highlights the ongoing dynamics within the pharmaceuticals and biotechnology industry.